3,4-Dimethylmethcathinone

From Wikipedia, the free encyclopedia
Jump to: navigation, search
3,4-Dimethylmethcathinone
3,4-DMMC.svg
Systematic (IUPAC) name
(±)-1-(3,4-dimethylphenyl)-2-(methylamino)propan-1-one
Clinical data
Legal status
?
Identifiers
CAS number 1081772-06-6 N
ATC code None
PubChem CID 52988261
ChemSpider 25630192 YesY
Chemical data
Formula C12H17NO 
Mol. mass 191.269 g/mol
 N (what is this?)  (verify)

3,4-Dimethylmethcathinone (3,4-DMMC) is a stimulant drug first reported in 2010 as a designer drug analogue of mephedrone, apparently produced in response to the banning of mephedrone, following its widespread abuse in many countries in Europe and around the world.[1] 3,4-DMMC has been seized as a designer drug in Australia.[2]

See also[edit]

References[edit]

  1. ^ EMCDDA Annual Report 2010
  2. ^ Locos, O.; Reynolds, D. (2012). "The Characterization of 3,4-Dimethylmethcathinone (3,4-DMMC)". Journal of Forensic Sciences 57 (5): 1303–1306. doi:10.1111/j.1556-4029.2012.02142.x. PMID 22564211.  edit